AUM $8.39BER 0.35%NAV $133.70Holdings 153Inception Jan 2006
Price Chart
Key Statistics
Previous Close
$134.75Day Range
$133.26$135.49
52-Week Range
$76.37$138.66
Avg Volume
8.2MDividend Yield
0.35%Expense Ratio
0.35%AUM
$8.39BShares Outstanding
62.0METF Grades
?ETF Grades compare this fund against others in the same category using percentile rankings across six factors. Grades range from A+ (top 5%) to F (bottom 20%). Updated daily.Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 99.83% |
| Financial Services | 0.17% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 95.76% |
| Ireland | 1.44% |
| Switzerland | 1.20% |
| United Kingdom | 1.06% |
| Netherlands | 0.36% |
| Other | 0.18% |
Fund Information
- Issuer
- SPDR
- Category
- Healthcare
- Inception Date
- Jan 31, 2006
- Exchange
- NYSE_ARCA
- Description
- The State Street SPDR S&P Biotech ETF seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index (the "Index")Seeks to provide exposure to the Biotechnology segment of the S&P TMI, which comprises the following sub-industries: BiotechnologySeeks to track a modified equal weighted index which provides the potential for unconcentrated industry exposure across large, mid and small cap stocksAllows investors to take strategic or tactical positions at a more targeted level than traditional sector based investing
Similar ETFs
The State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund issued by SPDR that launched on Jan 31, 2006. It currently manages $8.39B in assets under management. The fund charges an expense ratio of 0.35%. The fund holds 153 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 14.1% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | APLS | APELLIS PHARMACEUTICALS INC | 1.76% | 3,699,550 | $153.1M |
| 2 | RVMD | REVOLUTION MEDICINES INC | 1.61% | 928,360 | $140.3M |
| 3 | SMMT | SUMMIT THERAPEUTICS INC | 1.51% | 5,310,164 | $131.3M |
| 4 | TVTX | TRAVERE THERAPEUTICS INC | 1.44% | 3,124,272 | $125.1M |
| 5 | TGTX | TG THERAPEUTICS INC | 1.31% | 3,295,689 | $114.5M |
| 6 | MDGL | MADRIGAL PHARMACEUTICALS INC | 1.31% | 214,216 | $113.8M |
| 7 | ALKS | ALKERMES PLC | 1.31% | 3,328,974 | $113.8M |
| 8 | APGE | APOGEE THERAPEUTICS INC | 1.30% | 1,237,850 | $113.5M |
| 9 | TWST | TWIST BIOSCIENCE CORP | 1.29% | 1,973,013 | $112.3M |
| 10 | ARWR | ARROWHEAD PHARMACEUTICALS IN | 1.26% | 1,591,131 | $109.5M |
| 11 | BEAM | BEAM THERAPEUTICS INC | 1.25% | 3,544,790 | $108.9M |
| 12 | SRRK | SCHOLAR ROCK HOLDING CORP | 1.24% | 2,140,893 | $108.4M |
| 13 | CRSP | CRISPR THERAPEUTICS AG | 1.20% | 1,851,561 | $104.5M |
| 14 | PTCT | PTC THERAPEUTICS INC | 1.17% | 1,407,731 | $102.2M |
| 15 | BBIO | BRIDGEBIO PHARMA INC | 1.17% | 1,294,936 | $101.6M |
Page 1 of 4
Detailed Returns
| Period | Return | ETF |
|---|---|---|
| 1D | +0.02% | |
| 1W | +0.99% | |
| 1M | +2.10% | |
| 3M | +8.16% | |
| 6M | +20.47% | |
| YTD | +12.21% | |
| 1Y | +69.69% | |
| 3Y | +53.99% | |
| 5Y | +10.08% |
Moving Averages
20-Day MA
$134.42
Above 20-Day MA50-Day MA
$128.87
Above 50-Day MA200-Day MA
$114.57
Above 200-Day MAPrice with Moving Averages
Support & Resistance
52-Week High
$138.66
Current Price
$134.82
52-Week Low
$76.37
$76.37$138.66
Current Yield
0.35%
Annual Dividend
$0.4458
Frequency
4x/year
Last Ex-Date
Dec 22, 2025
Dividend History
| Ex-Date | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $0.4066 | Dec 24, 2025 |
| Sep 22, 2025 | $0.0267 | Sep 24, 2025 |
| Jun 23, 2025 | $0.0073 | Jun 25, 2025 |
| Mar 24, 2025 | $0.0053 | Mar 26, 2025 |
| Dec 23, 2024 | $0.0027 | Dec 26, 2024 |
| Sep 23, 2024 | $0.0152 | Sep 25, 2024 |
| Jun 24, 2024 | $0.1148 | Jun 26, 2024 |
| Dec 18, 2023 | $0.0139 | Dec 21, 2023 |
| Jun 20, 2023 | $0.0026 | Jun 23, 2023 |
| Mar 22, 2021 | $0.0400 | Mar 25, 2021 |
| Dec 21, 2020 | $0.1760 | Dec 24, 2020 |
| Sep 21, 2020 | $0.0890 | Sep 24, 2020 |
| Jun 22, 2020 | $0.0168 | Jun 25, 2020 |
| Dec 20, 2019 | $0.0009 | Dec 26, 2019 |
| Sep 20, 2019 | $0.0032 | Sep 25, 2019 |
| Dec 21, 2018 | $0.0120 | Dec 27, 2018 |
| Sep 21, 2018 | $0.0726 | Sep 26, 2018 |
| Jun 15, 2018 | $0.0585 | Jun 20, 2018 |
| Mar 16, 2018 | $0.0591 | Mar 21, 2018 |
| Dec 15, 2017 | $0.0347 | Dec 26, 2017 |
Dividend Payments Over Time
Category Comparison
| Metric | XBI | Healthcare(207 ETFs) | Equal Weight(109 ETFs) |
|---|---|---|---|
| Fund Info | |||
| Expense Ratio | 0.35% | 0.60% | 0.68% |
| AUM | $8.39B | $1.23B | $1.58B |
| Dividend Yield | 0.35% | 3.25% | 2.88% |
| Avg Volume | 8.2M | 363.2K | 537.6K |
| Holdings | 153 | 177 | 117 |
| Performance | |||
| 1-Month Return | +4.05% | +3.73% | +6.56% |
| 6-Month Return | +23.30% | +8.95% | +11.69% |
| YTD Return | +10.51% | +3.72% | +9.34% |
| 1-Year Return | +72.67% | +29.81% | +27.07% |
Compare with Another ETF
Search for an ETF to compare with XBI:
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.